Table 3.
Factors associated with co-MS according to the univariate analysis.
| Sarcopenia only (n = 43) | Co-MS (n = 29) | p-value | |
|---|---|---|---|
| Age | 85.79 | 87.34 | 0.506 |
| Length of stay (days) | 343.04 | 216.62 | 0.084 |
| CCI | 1.98 | 3.72 | <0.001 |
| <3a | 28 | 7 | |
| ≥3 | 15 | 22 | <0.001 |
| FILS score | 8.21 | 6.72 | 0.003 |
| <7b | 3 | 8 | |
| ≥7 | 40 | 21 | 0.017 |
| ROAG score | 10.51 | 13.97 | <0.001 |
| CPS score | 4.02 | 4.38 | 0.237 |
| Katz-ADL Index | 4.70 | 5.62 | 0.051 |
| Number of prescribed drugs | |||
| <5c | 15 | 6 | |
| ≥5 | 28 | 23 | 0.194 |
| Number of PIMs | |||
| 0 | 23 | 1 | |
| ≥1 | 20 | 28 | <0.001 |
Co-MS, malnutrition and sarcopenia; CCI, Charlson Comorbidity Index; FILS, Food Intake LEVEL Scale; ROAG, Revised Oral Assessment Guide; CPS, Cognitive Performance Scale; ADL, activities of daily living; PIMs, potentially inappropriate medications.
a
CCI<3 indicated mild to moderate comorbidity, and CCI≥3 indicated severe comorbidity.
b
FILS <7 indicated “no oral intake” and “oral intake and alternative nutrition,” and FILS ≥7 indicated “oral intake alone.” A FILS score of <7 indicated severe dysphagia.
c
Number of prescribed drugs ≥5 indicates polypharmacy.